ClinicalTrials.gov
ClinicalTrials.gov Menu

Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury (NNP-UE+T)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02329652
Recruitment Status : Recruiting
First Posted : December 31, 2014
Last Update Posted : March 15, 2018
Sponsor:
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Case Western Reserve University
Congressionally Directed Medical Research Programs
Information provided by (Responsible Party):
Kevin Kilgore, MetroHealth Medical Center

Brief Summary:

This study is to evaluate the use of a fully implanted device for providing hand function, reach, and trunk function to individuals with cervical spinal cord injury.

Funding Sources:

FDA OOPD NIH NINDS


Condition or disease Intervention/treatment Phase
Spinal Cord Injuries Device: Networked Neuroprosthetic System for Grasp and Trunk Not Applicable

Detailed Description:

The goal of this project is to restore these multiple functions to these individuals through a comprehensive neuroprosthetic approach that addresses the overall needs of the individual. This approach involves all aspects of the implementation, including the implanted technology, the surgical installation, and the outcomes assessment through a coordinated team approach in order to maximize the functional independence gained by the individual. With this system, we propose that individuals who have a mid-cervical-level spinal cord injury will regain control over multiple functions, including grasp, reach, bed mobility, seated posture, restoration of an effective cough and bladder function. This ambitious and exciting goal is made possible by the culmination of our research and clinical deployment of neuroprosthetic systems for spinal cord injured subjects over the past 30 years. We anticipate that this system will not only provide increased independence in each of the targeted body functions, but will provide enough of an overall benefit to demonstrate significant improvements in quality of life and health outcomes.

In clinical feasibility studies with spinal cord injured subjects, our clinical research teams have demonstrated the control of bilateral hand function, bed mobility, postural control, restoration of an effective cough, and bladder control using chronically implanted neuroprostheses. Outcomes from each clinical study demonstrate that each system provides increased functional independence to the individual. Initially, only a single type of implanted system was implemented in any one individual, resulting in restoration of a single bodily function. Thus, it has been necessary for subjects to choose between available functions and select only one, despite the fact that each subject had multiple disabilities. In the past few years, we have progressed to implementing a few subjects with more than one system, such as providing both hand function and trunk stability. However, the fundamental limitation of the current approach has been technological; i.e. each implanted system is completely independent (both technically and programmatically), requiring separate technology to be developed for each function, and these systems are implemented by separate teams in separate surgical procedures. Thus, to this point, it has not been possible to address each individual's comprehensive needs and tailor an overall approach that maximizes their functional gains.

The proposed approach depends on the availability of a foundational platform technology that is capable of meeting our broad specifications. We have now achieved this milestone under separate funding, creating a revolutionary new implantable neuroprosthetic technology that is fully capable of providing the necessary technological base for our proposed research. This system, the Networked Neuroprosthetic System (NNPS), is a modular, scalable, and configurable network of fully implanted, networked modules capable of meeting or exceeding the needs of all of these neuroprosthetic applications. The NNPS provides a foundation which enables efficient technical refinements that optimize implementation of the system for each targeted application. The NNPS technology is currently operational and is undergoing fabrication and testing in preparation for final pre-clinical studies and human implantation.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
Study Start Date : December 2014
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : December 2027

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention - implant neuroprosthesis
Receives implanted networked neuroprosthetic system for hand, arm, and trunk function. Undergoes functional training and assessment.
Device: Networked Neuroprosthetic System for Grasp and Trunk
Receive implanted networked neuroprosthesis




Primary Outcome Measures :
  1. Activities of Daily Living Abilities Test [ Time Frame: Three months post-implant ]
    Evaluation of ability to perform activities of daily living when using the neuroprosthesis compared to ability when the neuroprosthesis is turned off.


Secondary Outcome Measures :
  1. Grasp-Release Test [ Time Frame: Pre-implant and three months post-implant ]
    Ability to pick up, move, and release six standard objects.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   17 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of cervical level spinal cord injury, either complete or incomplete; International Standards for Neurological Classification of Spinal Cord Injury (INCSCI) motor level of C4 through C8; American Spinal Injury Impairment Scale (AIS) grade A, B, C, or D; six months or more post-injury
  • Biceps/brachialis/brachioradialis strength of 2/5 or higher on Manual Muscle Test
  • Peripheral nerve innervation to upper extremity and trunk muscles, including a grade 3/5 or higher stimulated strength (Manual Muscle Test) in at least two of the following muscles in one arm: adductor pollicis, abductor pollicis brevis, flexor pollicis longus, extensor pollicis longus, extensor digitorum communis, flexor digitorum superficialis, flexor digitorum profundus, pronator quadratus, extensor carpi ulnaris, extensor carpi radialis brevis, extensor radialis longus, flexor carpi ulnaris, flexor carpi radialis, first dorsal interosseous; and in at least two of the following muscles: left/right gluteus maximus, left/right erector spinae, left/right quadratus lumborum,
  • Age > 16 years
  • Medically stable - cleared for surgery
  • Able and willing to take part in study

Exclusion Criteria:

  • Currently pregnant (neuroprosthesis implantation delayed until no longer pregnant)
  • Other neurological conditions (multiple sclerosis, diabetes with peripheral nerve involvement)
  • History of coagulopathy, HIV, severe cardiopulmonary disease, severe bradycardia, severe autonomic dysreflexia, or chronic obstructive pulmonary disease.
  • Active untreated infection such as decubitus ulcer, urinary tract infection, pneumonia
  • Presence of other active implantable medical devices with unknown or untested interaction with the NNP implant
  • Active implantable medical device (AIMD) such as a pacemaker or defibrillator, with the exception of the implanted stimulator-telemeter (IST) or implanted receiver stimulator (IRS) systems developed by the Cleveland Functional Electrical Stimulation Center
  • Unhealed fractures that prevent functional use of arm or trunk
  • Less than six months post-injury (neuroprosthesis implantation delayed until criteria met)
  • Extensive upper extremity denervation (fewer than two stimulatable hand muscles and two stimulatable trunk muscles)
  • Involvement in other ongoing clinical studies that exclude concurrent until criteria met)
  • Disorder or condition that require MRI monitoring
  • Mechanical ventilator dependency
  • Progressive SCI In subjects who are undergoing bilateral implantation, subjects should not have a history of autonomic dysreflexia, hypertension, diabetes or any condition which requires frequent blood pressure monitoring or frequent venipuncture.
  • Adverse interaction between system components and typical electromagnetic (EM) sources in subject's home and work environments, including wheelchair or other active implantable devices.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02329652


Locations
United States, Ohio
MetroHealth Medical Center Recruiting
Cleveland, Ohio, United States, 44109
Contact: Kevin L Kilgore, Ph.D.       UE.FES.ClinicalTrials@gmail.com   
Principal Investigator: Kevin L Kilgore, Ph.D.         
Sponsors and Collaborators
Kevin Kilgore
National Institute of Neurological Disorders and Stroke (NINDS)
Case Western Reserve University
Congressionally Directed Medical Research Programs

Additional Information:
Publications of Results:
Other Publications:
Responsible Party: Kevin Kilgore, Principal Investigator, MetroHealth Medical Center
ClinicalTrials.gov Identifier: NCT02329652     History of Changes
Other Study ID Numbers: MetroHealthMC
U01NS069517 ( U.S. NIH Grant/Contract )
OPD #5409 ( Other Grant/Funding Number: FDA Office of Orphan Products Development )
UH2NS103863 ( U.S. NIH Grant/Contract )
First Posted: December 31, 2014    Key Record Dates
Last Update Posted: March 15, 2018
Last Verified: March 2018

Keywords provided by Kevin Kilgore, MetroHealth Medical Center:
Neuroprosthesis
Functional Electrical Stimulation

Additional relevant MeSH terms:
Wounds and Injuries
Spinal Cord Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System